Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowNet IncomeShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rallybio (RLYB) Cash from Financing Activities (2023 - 2025)

Historic Cash from Financing Activities for Rallybio (RLYB) over the last 3 years, with Q2 2025 value amounting to $10000.0.

  • Rallybio's Cash from Financing Activities fell 9980.74% to $10000.0 in Q2 2025 from the same period last year, while for Sep 2025 it was $28000.0, marking a year-over-year decrease of 9946.7%. This contributed to the annual value of $5.2 million for FY2024, which is 353566.43% up from last year.
  • Per Rallybio's latest filing, its Cash from Financing Activities stood at $10000.0 for Q2 2025, which was down 9980.74% from $18000.0 recorded in Q4 2024.
  • In the past 5 years, Rallybio's Cash from Financing Activities ranged from a high of $5.2 million in Q2 2024 and a low of -$139000.0 during Q1 2023
  • Its 3-year average for Cash from Financing Activities is $764571.4, with a median of $18000.0 in 2024.
  • In the last 5 years, Rallybio's Cash from Financing Activities skyrocketed by 237238.1% in 2024 and then plummeted by 9980.74% in 2025.
  • Rallybio's Cash from Financing Activities (Quarter) stood at $72000.0 in 2023, then crashed by 75.0% to $18000.0 in 2024, then plummeted by 44.44% to $10000.0 in 2025.
  • Its Cash from Financing Activities stands at $10000.0 for Q2 2025, versus $18000.0 for Q4 2024 and -$11000.0 for Q3 2024.